Stephen J. Meltzer

26.0k total citations · 3 hit papers
255 papers, 17.8k citations indexed

About

Stephen J. Meltzer is a scholar working on Molecular Biology, Surgery and Pathology and Forensic Medicine. According to data from OpenAlex, Stephen J. Meltzer has authored 255 papers receiving a total of 17.8k indexed citations (citations by other indexed papers that have themselves been cited), including 146 papers in Molecular Biology, 90 papers in Surgery and 74 papers in Pathology and Forensic Medicine. Recurrent topics in Stephen J. Meltzer's work include Genetic factors in colorectal cancer (71 papers), Esophageal Cancer Research and Treatment (65 papers) and RNA modifications and cancer (46 papers). Stephen J. Meltzer is often cited by papers focused on Genetic factors in colorectal cancer (71 papers), Esophageal Cancer Research and Treatment (65 papers) and RNA modifications and cancer (46 papers). Stephen J. Meltzer collaborates with scholars based in United States, China and Japan. Stephen J. Meltzer's co-authors include David Sidransky, Fumiaki Sato, John Abraham, Stanley R. Hamilton, Stephen N. Thibodeau, Guglielmina Nadia Ranzani, C. Richard Boland, Riccardo Fodde, Miguel A. Rodrı́guez-Bigas and Randall W. Burt and has published in prestigious journals such as Proceedings of the National Academy of Sciences, JAMA and Nucleic Acids Research.

In The Last Decade

Stephen J. Meltzer

247 papers receiving 17.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer.

1998 3.3k citations David Sidransky, Stephen J. Meltzer et al. PubMed profile →
6-Mercaptopurine in the Management of Inflammatory Bowel Disease: Short- and Long-Term Toxicity

1989 571 citations Stephen J. Meltzer et al. profile →
Increased expression of inducible nitric oxide synthase and cyclooxygenase-2 in Barrett's esophagus and associated adenocarcinomas.

1998 502 citations Stephen J. Meltzer et al. PubMed profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Stephen J. Meltzer United States	69	8.5k	6.1k	5.6k	5.4k	4.5k	255	17.8k
G. Johan A. Offerhaus Netherlands	67	5.7k 0.7×	4.6k 0.8×	9.6k 1.7×	3.8k 0.7×	5.9k 1.3×	235	18.1k
Lauri A. Aaltonen Finland	75	8.3k 1.0×	12.3k 2.0×	10.0k 1.8×	6.5k 1.2×	3.2k 0.7×	284	22.9k
Ragnhild A. Lothe Norway	67	7.3k 0.9×	4.8k 0.8×	5.5k 1.0×	4.3k 0.8×	2.5k 0.6×	292	15.1k
Raquel Seruca Portugal	63	6.3k 0.7×	4.5k 0.7×	3.8k 0.7×	2.4k 0.5×	3.9k 0.9×	236	13.1k
Wendy L. Frankel United States	53	4.2k 0.5×	3.9k 0.6×	6.5k 1.2×	4.4k 0.8×	2.9k 0.7×	273	13.8k
William M. Grady United States	55	6.2k 0.7×	3.7k 0.6×	4.8k 0.9×	3.1k 0.6×	1.9k 0.4×	189	11.8k
Gabriel Capellá Spain	58	6.6k 0.8×	3.7k 0.6×	5.5k 1.0×	3.5k 0.7×	1.6k 0.4×	302	12.9k
Manuel Sobrinho‐Simões Portugal	65	5.0k 0.6×	3.1k 0.5×	3.6k 0.6×	1.5k 0.3×	4.4k 1.0×	357	14.9k
Henry F. Frierson United States	70	5.8k 0.7×	2.1k 0.3×	4.3k 0.8×	2.3k 0.4×	4.3k 1.0×	237	14.7k
Jin Jen United States	61	9.2k 1.1×	5.1k 0.8×	6.3k 1.1×	4.8k 0.9×	1.4k 0.3×	156	16.0k

Countries citing papers authored by Stephen J. Meltzer

Since Specialization

Citations

This map shows the geographic impact of Stephen J. Meltzer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stephen J. Meltzer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stephen J. Meltzer more than expected).

Fields of papers citing papers by Stephen J. Meltzer

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stephen J. Meltzer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stephen J. Meltzer. The network helps show where Stephen J. Meltzer may publish in the future.

Co-authorship network of co-authors of Stephen J. Meltzer

This figure shows the co-authorship network connecting the top 25 collaborators of Stephen J. Meltzer. A scholar is included among the top collaborators of Stephen J. Meltzer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stephen J. Meltzer. Stephen J. Meltzer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Manyam, Ganiraju C., Vibhuti Srivastava, Jueping Song, et al.. (2025). Chromosome 20q gene signature associated with colorectal cancer progression. Oncology Reports. 54(4). 1–11.

Kann, Lisa, Suji Kim, Andrew Kalra, et al.. (2025). Spatiotemporal Study of a Risk-Stratification Epigenetic-Based Biomarker Assay in Patients With Barrett Esophagus. The American Journal of Gastroenterology. 120(6). 1285–1295. 5 indexed citations

Kim, Suji, et al.. (2024). Analytical Validation of Esopredict, an Epigenetic Prognostic Assay for Patients with Barrett’s Esophagus. Diagnostics. 14(18). 2003–2003.

Kong, Shuai, Dan Zhou, Yulan Cheng, et al.. (2024). Establishing mouse and human oral esophageal organoids to investigate the tumor immune response. Disease Models & Mechanisms. 17(1). 7 indexed citations

Cheng, Yulan, Andrew Kalra, Ke Ma, et al.. (2022). Generation and multiomic profiling of aTP53/CDKN2Adouble-knockout gastroesophageal junction organoid model. Science Translational Medicine. 14(673). eabq6146–eabq6146. 25 indexed citations

Wang, Zhixiong, Swetha Kambhampati, Yulan Cheng, et al.. (2019). Methylation Biomarker Panel Performance in EsophaCap Cytology Samples for Diagnosing Barrett's Esophagus: A Prospective Validation Study. Clinical Cancer Research. 25(7). 2127–2135. 42 indexed citations

Wang, Zhixiong, Yulan Cheng, John Abraham, et al.. (2017). RNA sequencing of esophageal adenocarcinomas identifies novel fusion transcripts, including NPC1‐MELK, arising from a complex chromosomal rearrangement. Cancer. 123(20). 3916–3924. 17 indexed citations

Michailidi, Christina, Ethan Soudry, Mariana Brait, et al.. (2014). Genome-Wide and Gene-Specific Epigenomic Platforms for Hepatocellular Carcinoma Biomarker Development Trials. Gastroenterology Research and Practice. 2014. 1–9. 11 indexed citations

Bi, Xiuli, Xin Song, Nicole M. Pohl, et al.. (2013). A sequence variant in the phospholipase C epsilon C2 domain is associated with esophageal carcinoma and esophagitis. Molecular Carcinogenesis. 52(S1). 80–86. 14 indexed citations

10.

Yang, Xue, Jueping Song, Yulan Cheng, et al.. (2013). Long non-coding RNA HNF1A-AS1 regulates proliferation and migration in oesophageal adenocarcinoma cells. Gut. 63(6). 881–890. 182 indexed citations

11.

Kathiria, Arwa S., William L. Neumann, Jennifer Rhees, et al.. (2012). Prohibitin Attenuates Colitis-Associated Tumorigenesis in Mice by Modulating p53 and STAT3 Apoptotic Responses. Cancer Research. 72(22). 5778–5789. 49 indexed citations

12.

Balaguer, Francesc, Leticia Moreira, Juan José Lozano, et al.. (2011). Colorectal Cancers with Microsatellite Instability Display Unique miRNA Profiles. Clinical Cancer Research. 17(19). 6239–6249. 95 indexed citations

13.

Mori, Yuriko, Alexandru Olaru, Yulan Cheng, et al.. (2011). Novel candidate colorectal cancer biomarkers identified by methylation microarray-based scanning. Endocrine Related Cancer. 18(4). 465–478. 63 indexed citations

14.

Ito, Tetsuo, Yutaka Shimada, Takatsugu Kan, et al.. (2008). Pituitary Tumor-Transforming 1 Increases Cell Motility and Promotes Lymph Node Metastasis in Esophageal Squamous Cell Carcinoma. Cancer Research. 68(9). 3214–3224. 44 indexed citations

15.

Jin, Zhe, Alexandru Olaru, Jian Yang, et al.. (2007). Hypermethylation of Tachykinin-1 Is a Potential Biomarker in Human Esophageal Cancer. Clinical Cancer Research. 13(21). 6293–6300. 67 indexed citations

16.

Hamilton, James P., Fumiaki Sato, Zhe Jin, et al.. (2006). Reprimo Methylation Is a Potential Biomarker of Barrett's-Associated Esophageal Neoplastic Progression. Clinical Cancer Research. 12(22). 6637–6642. 39 indexed citations

17.

Mori, Yuriko, Jing Yin, Fumiaki Sato, et al.. (2004). Identification of Genes Uniquely Involved in Frequent Microsatellite Instability Colon Carcinogenesis by Expression Profiling Combined with Epigenetic Scanning. Cancer Research. 64(7). 2434–2438. 57 indexed citations

18.

Deacu, Elena, Yuriko Mori, Fumiaki Sato, et al.. (2004). Activin Type II Receptor Restoration in ACVR2 -Deficient Colon Cancer Cells Induces Transforming Growth Factor-β Response Pathway Genes. Cancer Research. 64(21). 7690–7696. 36 indexed citations

19.

Mori, Yuriko, Jing Yin, Asma Rashid, et al.. (2001). Instabilotyping: comprehensive identification of frameshift mutations caused by coding region microsatellite instability.. PubMed. 61(16). 6046–9. 125 indexed citations

20.

Cawley, Helen, Stephen J. Meltzer, Monica Hollstein, et al.. (1998). Anti-p53 antibodies in patients with Barrett's esophagus or esophageal carcinoma can predate cancer diagnosis. Gastroenterology. 115(1). 19–27. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact